Natco gets USFDA tentative nod for generic Tamiflu

Natco Pharma today announced that it has received tentative approval from the US health regulator to sell generic version of Roche's Tamiflu, used to prevent and treat flu.

The tentative approval of Oseltamivir Phosphate (Tamiflu) capsules by the US Food and Drug Administration is for multiple strengths of 30mg, 45 mg and 75 mg, the company said in a filing to the BSE.

Natco may have first to file status for the abbreviated new drug application (ANDA), contingent upon successful litigation outcome of original drug patent 5,763,483.

The Hyderabad based company, citing IMS data, said Tamiflu had sales of approximately USD 495 million for the 12 months ending September 2013.

Shares of Natco Pharma were trading at Rs 832 per scrip in the afternoon trade, up 0.96 per cent from the previous close on the BSE.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Lower listings rate is proof that the Indian market is maturing

    The bullishness on Dalal Street notwithstanding, the pace at which new companies are being listed on Indian stock exchanges is declining.

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Arun Kumar Jain

Building great cities (and nations)

Fifteen to twenty years’ span is the time when humans ...

Rajgopal Nidamboor

The essence of amplified action

It is something that ‘separates’ us from other living creatures. ...

Shona Adhikari

All roads lead to Delhi, as it gears up for art fair

With the seventh edition of India Art Fair (IAF) coming ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture